| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 4.322 | 3.027 | 2.893 | 2.840 | 2.785 | 2.732 | 2.671 | 222 | 7.891 | - |
| Gross Profit/Loss - EUR | -4.322 | -3.027 | -2.893 | -2.840 | -2.785 | -2.732 | -2.671 | -222 | -7.891 | - |
| Net Profit/Loss - EUR | -4.322 | -3.027 | -2.893 | -2.840 | -2.785 | -2.732 | -2.671 | -222 | -7.891 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Casa 41 Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.169 | 14.957 | 11.811 | 8.754 | 5.800 | 2.958 | 221 | 0 | 0 | - |
| Current Assets | 18.543 | 18.354 | 18.043 | 17.712 | 17.369 | 17.040 | 16.661 | 16.713 | 8.772 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 38 | 37 | 37 | 36 | 35 | 35 | 34 | 34 | 34 | - |
| Cash | 18.505 | 18.316 | 18.006 | 17.676 | 17.334 | 17.005 | 16.628 | 16.680 | 8.738 | - |
| Shareholders Funds | 36.712 | 33.311 | 29.854 | 26.466 | 23.169 | 19.998 | 16.883 | 16.713 | 8.772 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6622 - 6622" | |||||||||
| CAEN Financial Year |
6622
|
|||||||||
Comments - Casa 41 Intermed Srl